Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model

E. de Nigris (Cambridge, United Kingdom), P. Mcewan (Cardiff, United Kingdom), U. Holmgren (Gothenburg, Sweden), J. Marshall (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), V. Foos (Cardiff, United Kingdom)

Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Session: COPD pharmacology: from basic science to real-world data
Session type: Oral Presentation
Number: 2944

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. de Nigris (Cambridge, United Kingdom), P. Mcewan (Cardiff, United Kingdom), U. Holmgren (Gothenburg, Sweden), J. Marshall (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), V. Foos (Cardiff, United Kingdom). Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model. 2944

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Determinants of long-term changes in ADO prognostic score in UK COPD primary care patients: results from The Health Improvement Network
Source: International Congress 2019 – Powerful cohort studies with/without lung function
Year: 2019



Development of the Birmingham Lung Improvement Studies (BLISS) prognostic score for COPD patients in primary care: data from the Birmingham COPD cohort
Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care
Year: 2019



Projections of 10-year mortality in patients with COPD in the UK using the CHOPIN policy model
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


The efficacy of COPD patients education: A paired matched case-control study
Source: International Congress 2014 – Best posters in chronic care
Year: 2014


Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Mortality predictive factors in COPD patients after a pulmonary rehabilitation programme - a 3 years study
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1
Year: 2014


Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Predictive value of annual costs on 3-year mortality in COPD
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015


Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Results of a pulmonary rehabilitation program (PRP) in COPD patients: Differences in outcomes according to currently 2011 GOLD groups
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014


The GOLD COPD categories are inaccurate in predicting future risk in a UK primary care dataset and the 2014 changes to cut-off values have not helped
Source: International Congress 2014 – Respiratory disease management in primary care
Year: 2014


A disease-specific integrated care intervention (ICI) prevents hospital admission only in COPD patients with recurrent hospitalisation
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Drug treatment in a German real-life COPD cohort (DACCORD)
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

COPD detected with screening: Impact on patient management and prognosis
Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care
Year: 2014



Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD)
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020


COPD patients' expectations of ICS/LABA therapy
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014

Validation of the COPD lung cancer screening score in a community based cohort of COPD patients
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015


Current and future costs of COPD in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013

Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014